"Varenicline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
Descriptor ID |
D000068580
|
MeSH Number(s) |
D03.633.100.079.900 D03.633.100.857.942
|
Concept/Terms |
Varenicline- Varenicline
- 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine
|
Below are MeSH descriptors whose meaning is more general than "Varenicline".
Below are MeSH descriptors whose meaning is more specific than "Varenicline".
This graph shows the total number of publications written about "Varenicline" by people in this website by year, and whether "Varenicline" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2022 | 0 | 2 | 2 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Varenicline" by people in Profiles.
-
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV. AIDS. 2024 04 01; 38(5):669-678.
-
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial. Addiction. 2024 04; 119(4):664-676.
-
Trapping of Nicotinic Acetylcholine Receptor Ligands Assayed by In Vitro Cellular Studies and In Vivo PET Imaging. J Neurosci. 2023 01 04; 43(1):2-13.
-
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease. J Manag Care Spec Pharm. 2022 Aug; 28(8):892-902.
-
Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 01; 5(3):e220951.
-
Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks. Neuropsychopharmacology. 2020 04; 45(5):857-865.
-
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence? Nicotine Tob Res. 2019 08 19; 21(9):1289-1293.
-
Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation. Elife. 2017 07 18; 6.
-
Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry. 2013 Dec; 170(12):1460-7.
-
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res. 2012 May; 36(5):906-14.